Skip to main content
OpenTrials
Completed

NCT Number: NCT05598138

Clinical and Biological Strokes Collection in Reunion Island

Cross-sectional regional multicenter hospital study of all neurological events (stroke, AIT and mimics) for diagnostic and prognostic purposes. Cost of illness study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de La Réunion, Saint-Denis, Reunion

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • affiliated to a social security scheme
  • clinical signs suggestive of stroke : hemiparesis or hemiplegia, unilateral sensory disorder, language disorder, balance disorder, dizziness, loss of total or partial bilateral or monocular vision, sudden neurological deficit

Exclusion criteria

  • current pregnancy
  • Recent clinical history of head trauma
  • patients aged < 18 years old
  • patient under guardianship or curatorship
  • Person deprived of liberty

Treatment and study plan

Biological collection

Biological

A blood sample (10 ml) will be taken for each patient included in the study.

Primary outcomes

  1. clinico-biological score

    Time frame: 24 hours after the stroke

    area under the diagnostic score curve identifying ischemic stroke, stroke hemorrhagic or mimics.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de la Réunion

Other

Registry information

Acronym: CoBRA

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Oct 28, 2022
Registry last updated
Sep 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.